SIMONE MICHAELA SIMONS

Projetos de Pesquisa
Unidades Organizacionais
Cargo

Resultados de Busca

Agora exibindo 1 - 1 de 1
  • Artigo IPEN-doc 18035
    Pro-apoptotic effects of amblyomin-X in murine renal cell carcinoma 'in-vitro'
    2012 - AKAGI, ERICA M.; SA JUNIOR, PAULO L. de; SIMONS, SIMONE M.; BELLINI, MARIA H.; BARRETO, SANDRA A.; CHUDZINSKI-TAVASSI, ANA M.
    Renal cell carcinoma (RCC) is one of the most lethal urologic cancers and is highly resistant to both radiotherapy and chemotherapy. The recombinant protein Amblyomin-X, characterized as a Kunitz-type protease inhibitor, was obtained from a cDNA library from the salivary glands of the Amblyomma cajennense tick. This paper reports the biological effect of Amblyomin-X on inducing cell death by apoptotic process in vitro. For this purpose, the changes in morphological aspects of cells, the phosphatidylserine exposition and DNA degradation were evaluated after treatment with Amblyomin- X. We found that Amblyomin-X was able to induce apoptosis in Renca cells in a dose-dependent manner. So, the results presented here open perspectives for new researches and developing for Amblyomin-X in the treatment of RCC.